Patent · US Active

Compositions and methods for inhibiting cytochrome P450

US9233952B2 · kind B2 · utility

0Cited by
4References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 9, 2013
Grant dateJan 12, 2016
Priority date
Expiry dateAug 4, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/048
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 enzymes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.